Stratford, CT October 4th, 2018 –- Kubtec announces Fearless Friday (#FearlessFriday) for Breast Cancer Awareness Month – sharing stories of hope, courage and survival - as we continue the fight for people combating breast cancer.
As an organization committed to improving the quality of care for breast cancer patients, we celebrate the joy, hope, compassion and determination of each and every woman (and a few men) as they embark upon their personal fight against the disease.
Each Friday, during October's Breast Cancer Awareness Month, we will be featuring stories from breast cancer patients, told in their own words, as they tell their unique stories of their fight against breast cancer.

Ad Statistics
Times Displayed: 349388
Times Visited: 21070 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
You can read and follow these survivor's stories with #FearlessFriday on Twitter, Facebook and LinkedIn.
"One in eight women can expect to be diagnosed with breast cancer in their lifetime", says Vikram Butani, Kubtec CEO. "Although treatment continues to improve, the challenges of helping women feel their best, during and after treatment remains our focus. Kubtec stands with all breast cancer patients and will continue to find ways to improve their quality of care and quality of life."
At Kubtec®, our passion is producing diagnostic imaging systems that enable medical professionals to provide the best quality of care for patients. Our pioneering advances, such as 3‑D breast specimen tomosynthesis for breast cancer treatment, are redefining medical imaging and healthcare standards for the 21st century.
Used by medical imaging departments at centers of excellence worldwide, our award-winning diagnostic imaging systems such as the Mozart® ensure the highest level of performance and thereby results when it comes to breast cancer treatment and beyond.